Ду Центр громадського здоровя Міністерства охорони здоровя України
 Скачать 0.7 Mb.
|
|
282-329). London, UK: Informa Healthcare. Dunn, C., Deroo, L., & Rivara, F. P. (2001). The use of brief interventions adapted from motivational interviewing across behavioral domains: a systematic review. Addiction, 96(12), 17251742. Dyer, K. R. (2005). Methadone maintenance treatment and mood disturbances: Pharmacological and psychological implications. Heroin Addiction & Related Clinical Problems, 7(2), 5-10. Dyer, K. R., & White, J. M. (1997). Patterns of symptom complaints in methadone maintenance patients. Addiction, 92(11), 1445-1455. Eap, C. B., Buclin, T., & Baumann, P. (2002). Interindividual variability of the clinical pharmacokinetics of methadone. Clinical Pharmacokinetics, 41(14), 1153-1193. Egli, N., Pina, M., Christensen, P. S., Aebi, M., & Killias, M. (2009). Effects of drug substitution programs on offending among drug-addicts. Campbell Systematic Reviews, 3. Eissenberg, T., Greenwald, M. K., Johnson, R. E., Liebson, I. A., Bigelow, G. E., & Stitzer, M. L. (1996). Buprenorphine’s physical dependence potential: antagonist-precipitated withdrawal in humans. Journal of Pharmacology and Experimental Therapeutics, 276(2), 449-459. el-Guebaly, N. (2012). The meanings of recovery from addiction: evolution and promises. Journal of Addiction Medicine, 6(1), 1-9. Elkader, A., & Sproule, B. (2005). Buprenorphine: Clinical pharmacokinetics in the treatment of opioid dependence. Clinical Pharmacokinetics, 44(7), 661-680. Elkader, A. K., Brands, B., Selby, P., & Sproule, B. A. (2009). Methadone-nicotine interactions in methadone maintenance treatment patients. Journal of Clinical Psychopharmacology, 29(3), 231-238. Faggiano, F., Vigna-Taglianti, F., Versino, E., & Lemma, P. (2003). Methadone maintenance at different dosages for opioid dependence. Cochrane Database of Systematic Reviews(3). doi: 10.1002/14651858.CD002208 Fajemirokun-Odudeyi, O., Sinha, C., Tutty, S., Pairaudeau, P., Armstrong, D., Phillips, T., & Lindow, S. W. (2006). Pregnancy outcome in women who use opiates. European Journal of Obstetrics, Gynecology, and Reproductive Biology, 126(2), 170-175. Faroqui, M. H., Cole, M., & Curran, J. (1983). Buprenorphine, benzodiazepines and respiratory depression. Anaesthesia, 38(10), 1002-1003. Ferri, M., Davoli, M., & Perucci, C. A. (2011). Heroin maintenance for chronic heroindependent individuals. Cochrane Database of Systematic Reviews(12). doi: 10.1002/14651858.CD003410.pub4 Fiorentine, R., & Hillhouse, M. P. (2000). Self-efficacy, expectancies, and abstinence acceptance: further evidence for the addicted-self model of cessation of alcohol- and drug-dependent behaviour. American Journal of Drug and Alcohol Abuse, 26(4), 497-521. Fischer, G., Gombas, W., Eder, H., Jagsch, R., Peternell, A., Stuhlinger, G., ... Kasper, S. (1999). Buprenorphine versus methadone maintenance for the treatment of opioid dependence. Addiction, 94(9), 1337-1347. Flynn, P. M., & Brown, B. S. (2008). Co-occurring disorders in substance abuse treatment: Issues and prospects. Journal of Substance Abuse Treatment, 34(1), 36-47. Forrest, A. L. (1983). Buprenorphine and lorazepam. Anaesthesia, 38(6), 598. Fudala, P. J., Jaffe, J. H., Dax, E. M., & Johnson, R. E. (1990). Use of buprenorphine in the treatment of opioid addiction. II. Physiologic and behavioral effects of daily and alternate-day administration and abrupt withdrawal. Clinical Pharmacology and Therapeutics, 47(4), 525-534. Gaalema, D. E., Scott, T. L., Heil, S. H., Coyle, M. G., Kaltenbach, K., Badger, G. J., ... Jones, H. E. (2012). Differences in the profile of neonatal abstinence syndrome signs in methadone-versus buprenorphine-exposed neonates. Addiction, 107(Suppl 1), 53-62. Gal, T. J. (1989). Naloxone reversal of buprenorphine-induced respiratory depression. Clinical Pharmacology and Therapeutics, 45(1), 66-71. Galanter, M. (2006). Spirituality in Alcoholics Anonymous: A valuable adjunct to psychiatric services. Psychiatric Services, 57(3), 307-309. Gaulier, J. M., Charvier, F., Monceaux, F., Marquet, P., & Lachatre, G. (2004). Ingestion of high-dose buprenorphine by a 4 year-old child. Journal of Toxicology-Clinical Toxicology, 42(7), 993-995. Gerra, G., Di Petta, G., D’Amore, A., Ianotta, P., Bardicchia, F., Falorni, F., ... Zaimovic, A. (2007). Combination of olanzapine with opioid-agonists in the treatment of heroin-addicted patients affected by comorbid schizophrenia spectrum disorders. Clinical Neuropharmacology, 30(3), 127135. Gerra, G., Leonardi, C., D’Amore, A., Strepparola, G., Fagetti, R., Assi, C., ... Lucchini, A. (2006). Buprenorphine treatment outcome in dually diagnosed heroin dependent patients: a retrospective study. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 30(2), 265272. Gerstein, D. R., Johnson, R. A., Harwood, H. J., Fountain, D., Suter, N., & Malloy, K. (1994). Evaluation Recovery Services: The California drug and alcohol treatment assessment (CALDATA). Sacramento, California: Department of Alcohol and Drug Programs. Giacomuzzi, S., Haaser, W., Pilsz, L., & Riemer, Y. (2005). Driving impairment on buprenorphine and slow-release oral morphine in drug-dependent patients. Forensic Science International, 152(2-3), 323-324. Gibson, J. C., & Vulliamy, A. (2010). Accidental methadone poisoning in children: a call for Canadian research action. Child Abuse and Neglect, 34(8), 553-554. Gjersing, L., Waal, H., Caplehorn, J. R. M., Gossop, M., & Clausen, T. (2010). Staff attitudes and the associations with treatment organisation, clinical practices and outcomes in opioid maintenance treatment. BMC Health Services Research, 10, 194. Gonzalez, J. P., & Brogden, R. N. (1988). Naltrexone: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the management of opioid dependence. Drugs, 35, 192-213. Gordon, A. (2008). Comorbidity of mental disorders and substance use: A brief guide for the primary care clinician. National Drug Strategy Monograph Series, 71. Retrieved from http://www.nationaldrugstrategy.gov.au/internet/drugstrategy/publishing.nsf/Content/mono71 Gossop, M. (2011). Treating drug misuse problems: evidence of effectiveness. London, UK: National Treatment Agency for Substance Misuse. Retrieved from www.nta.nhs.uk Gossop, M., Griffiths, P., Bradley, B., & Strang, J. (1989). Opiate withdrawal symptoms in response to 10 day and 21 day methadone withdrawal programmes. British Journal of Psychiatry, 154, 360-363. Gossop, M., Marsden, J., Stewart, D., & Rolfe, A. (2000). Patterns of improvement after methadone treatment: 1 year follow-up results from the National Treatment Outcome Research Study (NTORS). Drug and Alcohol Dependence, 60, 275-286. Gossop, M., & Strang, J. (1997). Rapid anaesthetic-antagonist detoxification of heroin addicts: What origins, evidence and clinical justification? British Journal of Intensive Care, 7(2), 6669. Gourarier, L., Lowenstein, W., Gisselbrecht, M., Chauveau, J. M., Haas, C., & Durand, H. (1996). [Withdrawal syndrome in 2 drug addicts after intravenous injection of buprenorphine?] Syndrome de manque chez deux toxicomanes apres injection intraveineuse de buprenorphine? Presse Medicale, 25(27), 1239-1240. Gowing, L., Ali, R., & White, J. (2009a). Buprenorphine for the management of opioid withdrawal. Cochrane Database of Systematic Reviews(3). doi: 10.1002/14651858.CD002025.pub3 Gowing, L., Ali, R., & White, J. M. (2009b). Opioid antagonists with minimal sedation for opioid withdrawal. Cochrane Database of Systematic Reviews(4). doi: 10.1002/14651858.CD002021.pub3 Gowing, L., Ali, R., & White, J. M. (2010). Opioid antagonists under heavy sedation or anaesthesia for opioid withdrawal. Cochrane Database of Systematic Reviews(1). doi: 10.1002/14651858.CD002022.pub3 Gowing, L., Farrell, M., Bornemann, R., Sullivan, L., & Ali, R. (2011). Substitution treatment of injecting opioid users for prevention of HIV infection. Cochrane Database of Systematic Reviews(8). doi: 10.1002/14651858.CD004145.pub2 Gowing, L., Proudfoot, H., Henry-Edwards, S., & Teesson, M. (2001). Evidence supporting treatment: the effectiveness of interventions for illicit drug use. Canberra: Australian National Council on Drugs. Gowing, L. R., & Ali, R. L. (2006). The place of detoxification in treatment of opioid dependence. Current Opinion in Psychiatry, 19(3), 266-270. Greenfield, S. F., Brooks, A. J., Gordon, S. M., Green, C. A., Kropp, F., McHugh, R. K., ... Miele, G. M. (2007). Substance abuse treatment entry, retention, and outcome in women: A review of the literature. Drug and Alcohol Dependence, 86, 1-21. Greenwald, M. K. (2002). Heroin craving and drug use in opioid-maintained volunteers: Effects of methadone dose variations. Experimental and Clinical Psychopharmacology, 10(1), 39-46. Grella, C. E., & Lovinger, K. (2011). 30-Year trajectories of heroin and other drug use among men and women sampled from methadone treatment in California. Drug and Alcohol Dependence, 118, 251-258. Groh, D. R., Jason, L. A., & Keys, C. B. (2008). Social network variables in alcoholics anonymous: A literature review. Clinical Psychology Review, 28, 430-450. Groshkova, T., Best, D., & White, W. (2013). The assessment of recovery capital: Properties and psychometrics of a measure of addiction recovery strengths. Drug and Alcohol Review, 32, 187194. Gruber, V. A., Delucchi, K. L., Kielstein, A., & Batki, S. L. (2008). A randomized trial of 6- month methadone maintenance with standard or minimal counseling versus 21-day methadone detoxification. Drug and Alcohol Dependence, 94(1-3), 199-206. Hall, K., Gibbie, T., & Lubman, D. I. (2012). Motivational interviewing techniques: Facilitating behaviour change in the general practice setting. Australian Family Physician, 41(9), 660-667. Hall, W. (1996). Methadone maintenance treatment as a crime control measure. Crime and Justice Bulletin(29). Hall, W., Ward, J., & Mattick, R. P. (1998). The effectiveness of methadone maintenance treatment 1: Heroin use and crime. In J. Ward, R. P. Mattick & W. Hall (Eds.), Methadone Maintenance Treatment and Other Opioid Replacement Therapies (pp. 17-57). Amsterdam: Harwood Academic Publishers. Harris, D. S., Mendelson, J. E., Lin, E. T., Upton, R. A., Jones, R. T., Harris, D. S., ... Jones, R. T. |